Therefore, this study analyzed chemical components of TX using UPLC-Q-TOF-MS/MS, predicted potential mechanism through transcriptomic analysis, and confirmed its activation of the PI3K-AKT signaling pathway for treating RCC through in vitro cell experiments. Here, AKT1 is linked to renal cell carcinoma.